Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frauke Zipp

Showing results (61-70 of 317) with videos related to

Pageof 32
Sort By:
Therapeutic Advances in Neurological Disorders|August 30, 2021
Treatment approaches to patients with multiple sclerosis and coexisting autoimmune disordersTobias Brummer, Tobias Ruck, Sven G Meuth, et al.
Cancers|July 24, 2021
Targeting Immune Modulators in Glioma While Avoiding Autoimmune ConditionsLynn Bitar, Ulrike Schumann, Renate König, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 11, 2016
Phenotype of Antigen Unexperienced T<sub>H</sub> Cells in the Inflamed Central Nervous System in Experimental Autoimmune EncephalomyelitisSophia Franck, Magdalena Paterka, Jerome Birkenstock, et al.
Therapeutic Advances in Neurological Disorders|April 28, 2025
Atypical adverse events in a real-world study of long-term immunomodulation for multiple sclerosis and neuromyelitis optica spectrum disorderAmelie Kirschbaum, Felix Luessi, Arda Civelek, et al.
Radiology|June 1, 2016
Metabolic Patterns in Chronic Multiple Sclerosis Lesions and Normal-appearing White Matter: Intraindividual Comparison by Using 2D MR Spectroscopic ImagingVinzenz Fleischer, Rupert Kolb, Sergiu Groppa, et al.
Journal of Central Nervous System Disease|January 7, 2022
A Case of Progressive Multifocal Leukoencephalopathy in a Fumaric Acid-Treated Psoriasis Patient With Severe Lymphopenia Among Other Risk FactorsSinah Engel, Lara S Molina Galindo, Stefan Bittner, et al.
Ebiomedicine|December 19, 2022
Predictors for insufficient SARS-CoV-2 vaccination response upon treatment in multiple sclerosisMuriel Schraad, Timo Uphaus, Stefan Runkel, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|July 11, 2020
Neuropsychological Symptoms After Anterior Cerebral Artery Ischemic StrokeMichael Kim, Annette Spreer, Hannah Cuvenhaus, et al.
Frontiers in Oncology|December 11, 2023
Case Report: Balancing immune responses - multiple sclerosis disease exacerbation under BRAF/MEK treatment for malignant melanomaKatrin Pape, Maria Protopapa, Muriel Schraad, et al.
Frontiers in Neuroscience|February 13, 2016
Structural Brain Network Characteristics Can Differentiate CIS from Early RRMSMuthuraman Muthuraman, Vinzenz Fleischer, Pierre Kolber, et al.
Pageof 32

Showing results (61-70 of 317) with videos related to

Sort By:
Pageof 32
Therapeutic Advances in Neurological Disorders|August 30, 2021
Treatment approaches to patients with multiple sclerosis and coexisting autoimmune disordersTobias Brummer, Tobias Ruck, Sven G Meuth, et al.
Cancers|July 24, 2021
Targeting Immune Modulators in Glioma While Avoiding Autoimmune ConditionsLynn Bitar, Ulrike Schumann, Renate König, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 11, 2016
Phenotype of Antigen Unexperienced T<sub>H</sub> Cells in the Inflamed Central Nervous System in Experimental Autoimmune EncephalomyelitisSophia Franck, Magdalena Paterka, Jerome Birkenstock, et al.
Therapeutic Advances in Neurological Disorders|April 28, 2025
Atypical adverse events in a real-world study of long-term immunomodulation for multiple sclerosis and neuromyelitis optica spectrum disorderAmelie Kirschbaum, Felix Luessi, Arda Civelek, et al.
Radiology|June 1, 2016
Metabolic Patterns in Chronic Multiple Sclerosis Lesions and Normal-appearing White Matter: Intraindividual Comparison by Using 2D MR Spectroscopic ImagingVinzenz Fleischer, Rupert Kolb, Sergiu Groppa, et al.
Journal of Central Nervous System Disease|January 7, 2022
A Case of Progressive Multifocal Leukoencephalopathy in a Fumaric Acid-Treated Psoriasis Patient With Severe Lymphopenia Among Other Risk FactorsSinah Engel, Lara S Molina Galindo, Stefan Bittner, et al.
Ebiomedicine|December 19, 2022
Predictors for insufficient SARS-CoV-2 vaccination response upon treatment in multiple sclerosisMuriel Schraad, Timo Uphaus, Stefan Runkel, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|July 11, 2020
Neuropsychological Symptoms After Anterior Cerebral Artery Ischemic StrokeMichael Kim, Annette Spreer, Hannah Cuvenhaus, et al.
Frontiers in Oncology|December 11, 2023
Case Report: Balancing immune responses - multiple sclerosis disease exacerbation under BRAF/MEK treatment for malignant melanomaKatrin Pape, Maria Protopapa, Muriel Schraad, et al.
Frontiers in Neuroscience|February 13, 2016
Structural Brain Network Characteristics Can Differentiate CIS from Early RRMSMuthuraman Muthuraman, Vinzenz Fleischer, Pierre Kolber, et al.
Pageof 32